Published in Cancer Weekly, October 9th, 2001
In the first step, carried out at NCI under the direction of Dr. Larry Kwak, the study showed that a highly purified patient-specific cancer antigen could be produced and formulated by a patented process into a liposomal formulation that also...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.